Health ❯Healthcare ❯Pharmaceuticals ❯Weight Loss

GLP-1 Drugs

Serena Williams Discloses 31-Pound Loss With GLP-1, Goes Public With Ro Partnership

Her announcement coincides with a paid ambassador role at telehealth provider Ro, where her husband sits on the board.

Lilly’s Oral GLP-1 Pill Underperforms Wegovy in Late-Stage Trial

NICE Requires Yearlong Follow-Up for NHS Weight-Loss Injection Patients

GLP-1 Weight-Loss Drugs Fail to Boost Fitness and Cause Significant Muscle Loss

NHS Expands Mounjaro Prescriptions to Highest-Risk Patients as Safety Warnings Grow

UK Regulator Probes Pancreatitis Cases Linked to GLP-1 Weight-Loss Drugs

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Weight Management Revolution: GLP-1 Drugs Dominate as Pills Emerge

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

Access to Popular Weight-Loss Drugs Faces Challenges Amid Cost and Coverage Issues

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs